A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)

NCT07013487 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

12000

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: V181
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC